<DOC>
	<DOCNO>NCT01686295</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness iRestore Hair Rejuvenation System use direct promote hair growth men woman androgenetic alopecia</brief_summary>
	<brief_title>24 Week Clinical Trial Evaluate Safety Effectiveness Hair Growth System Treat Male Female Baldness</brief_title>
	<detailed_description>The test treatment iRestore™ Hair Rejuvenation System . The device irradiate scalp visible light use 5 mW ( class 3a ) laser . It use approximately 3 time per week approximately 30 minute session . The System place head adjust comfortable size rotate knob side device . If need , subject may replace soft pad inside device thinner pad provide . There 2 option use product . The subject either insert 5-V AC power adapter pin device remote control , 5-V adapter plug AC outlet ; subject use rechargeable battery pack belt clip . The battery pack external device allow subject freedom mobility treat hair . The rechargeable battery pack hold charge 3 hour prior need recharge . The iRestore™ remote control clip battery holster pack plug remote . The battery pack place pocket , clip belt place next subject . The device turn press power button remote control . The dome device move forward backward subject brush hair increase direct light come contact scalp . Subjects position dome front scalp press start button begin 10-minute session . Note : As safety feature , dome must place onto head prior start device . A timer indicate completion session beep sound . Subjects complete process do front scalp dome reposition middle scalp back scalp . Once 3 position receive 10 minute treatment , power button hold approximately 3 second turn device . Once device unplug wall . The control device identical test device except laser-emitting unit disable . A standard light emit device . Subjects clinical staff engage performance assessment treatment blind .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>Individuals eligible inclusion study : 1 . Are male female , 25 60 year age ; 2 . If male , NorwoodHamilton classification IIa V male pattern baldness ; 3 . If female , Ludwig Scale classification I4 , II1 , II2 , frontal ; 4 . Are willing tattoo create target area ; 5 . Have experience active hair loss within last 12 month ; 6 . In case female childbearing potential , use acceptable form birth control ( oral/implant/injectable/transdermal contraceptive , intrauterine device , condom spermicide , diaphragm spermicide , abstinence partner 's vasectomy : abstinence partner 's vasectomy acceptable female agree implement one acceptable method birth control lifestyle partner change ) ; 7 . Have Fitzpatrick Skin Type IIV ( See Table 1 Below ) ; 8 . Are willing target area hair clip ; 9 . Read , understand , sign photographic release form ( ) ; 10 . Read , understand , sign inform consent document advise nature study . Table 1 : Fitzpatrick Skin Types I Always burn easily , never tan II Always burn easily , tan minimally III Burns moderately , tan gradually ( light brown ) IV Burns minimally , always tan well ( moderate brown ) V Rarely burn , tan well ( moderate brown ) VI Never burn , deeply pigmented Individuals exclude participation study : 1 . Have use following medication within 6 month prior enrollment : minoxidil , finasteride ( 5αreductase inhibitor medication ) ; medication antiandrogenic property ( eg , cyproterone , spironolactone , ketoconazole , flutamide , bicalutamide ) ; topical estrogen , progesterone , tamoxifen , anabolic steroid ; medication potentially cause hypertrichosis ( eg , ciclosporin , diazoxide , phenytoin , psoralens ) ; oral glucocorticoid ( inhaled glucocorticoid permit ) ; lithium phenothiazine ; medication know suspected phototoxicity ( eg , tetracycline , thiazide , certain NSAIDs ) ; medication , opinion investigator , may interfere performance study assessment place subject undue risk ; 2 . Will agree refrain change hair color hair style course study ; 3 . Have hair transplant , scalp reduction , hair weave , tattoo , opinion investigator , may interfere performance study assessment ; 4 . Are use used depilatory , razor , wax scalp extent , opinion investigator , may interfere performance study assessment ; 5 . Have psoriasis , active dermatitis/eczema , severe acne scalp area ; 6 . Have diabetes require exogenous insulin ; 7 . Have cataract ; 8 . Have medical condition , opinion investigator , could affect hair growth ( eg , Human Immunodeficiency Virus , connective tissue disease , inflammatory bowel disease ) ; 9 . Have little contrast hair color scalp , eg , fair hair color ( eg , white blond ) pale skin ; 10 . Are females pregnant , plan become pregnant study , breastfeed ; and/or 11 . Are , opinion investigative personnel , unable comprehend and/or otherwise comply aspect study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>androgenetic alopecia</keyword>
	<keyword>Baldness</keyword>
</DOC>